NATURAL SEROCONVERSION FROM HEPATITIS-BE ANTIGEN TO ANTIBODY AMONG HEPATITIS-B VIRUS CARRIERS IN OKINAWA-ISLANDS

被引:21
作者
SAKUGAWA, H [1 ]
OHWAN, T [1 ]
YAMASHIRO, A [1 ]
OYAKAWA, T [1 ]
KADENA, K [1 ]
KINJO, F [1 ]
SAITO, A [1 ]
机构
[1] UNIV RYUKYUS,SCH MED,FAC MED,DEPT INTERNAL MED 1,NAHA,OKINAWA 903,JAPAN
关键词
HEPATOCELLULAR CARCINOMA; HBV; ANTI-HBE;
D O I
10.1002/jmv.1890340210
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the Okinawa Islands, the great majority of hepatitis B surface antigen (HBsAg) carriers have already acquired antibody to hepatitis Be antigen (anti-HBe) by the age of 30 years (preliminary cross-sectional data). To elucidate natural seroconversion from hepatitis Be antigen (HBeAg) to anti-HBe among HBsAg carriers found in the islands of Okinawa Prefecture, 34 HBeAg-positive HBsAg carriers were followed for 1-6 years with serial measurements of aminotransferase levels, HBeAg, and anti-HBe. The 34 subjects included 24 patients with chronic hepatitis (group 1) and ten asymptomatic HBsAg carriers (group 2). During the follow-up period, HBeAg disappeared from 14 subjects in group 1 with the cumulative clearance rate of HBeAg of 56.3% within the first 2 years and with 10 of the 14 subsequently developing anti-HBe. Moreover, the aminotransferases in 12 of the 14 spontaneously seroconverted fell into the normal range. The annual clearance rates of HBeAg among group 1 and group 2 were 25.6% and 9.3%, respectively. The tendency for early disappearance of HBeAg during a carrier's life time or in the course of chronic hepatitis may lead to the low death rate from hepatocellular carcinoma (HCC) particularly HCC associated with hepatitis B virus infection in this area.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 29 条
  • [1] THE EXPRESSION PATTERN OF HEPATITIS-B E-ANTIGEN AND ANTIBODY IN DIFFERENT ETHNIC AND CLINICAL GROUPS OF HEPATITIS-B SURFACE-ANTIGEN CARRIERS
    ALDERSHVILE, J
    SKINHOJ, P
    FROSNER, GG
    BLACK, F
    DEINHARDT, F
    HARDT, F
    NIELSEN, JO
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (01) : 18 - 22
  • [2] BEASLEY RP, 1981, LANCET, V2, P1129
  • [3] WHICH PATIENTS WITH CHRONIC HEPATITIS-B VIRUS-INFECTION WILL RESPOND TO ALPHA-INTERFERON THERAPY - A STATISTICAL-ANALYSIS OF PREDICTIVE FACTORS
    BROOK, MG
    KARAYIANNIS, P
    THOMAS, HC
    [J]. HEPATOLOGY, 1989, 10 (05) : 761 - 763
  • [4] NATURAL-HISTORY OF CHRONIC HEPATITIS-B VIRUS-INFECTION IN TAIWAN - STUDIES OF HEPATITIS-B VIRUS-DNA IN SERUM
    CHU, CM
    KARAYIANNIS, P
    FOWLER, MJF
    MONJARDINO, J
    LIAW, YF
    THOMAS, HC
    [J]. HEPATOLOGY, 1985, 5 (03) : 431 - 434
  • [5] DOW BC, 1980, J CLIN PATHOL, V33, P1160
  • [6] CLINICAL, VIROLOGICAL AND HISTOLOGIC OUTCOME FOLLOWING SEROCONVERSION FROM HEBEAG TO ANTI-HBE IN CHRONIC HEPATITIS TYPE-B
    FATTOVICH, G
    RUGGE, M
    BROLLO, L
    PONTISSO, P
    NOVENTA, F
    GUIDO, M
    ALBERTI, A
    REALDI, G
    [J]. HEPATOLOGY, 1986, 6 (02) : 167 - 172
  • [7] CHRONIC TYPE-B HEPATITIS AND THE HEALTHY HBSAG CARRIER STATE
    HOOFNAGLE, JH
    SHAFRITZ, DA
    POPPER, H
    [J]. HEPATOLOGY, 1987, 7 (04) : 758 - 763
  • [8] SEROCONVERSION FROM HEPATITIS-B-E ANTIGEN TO ANTIBODY IN CHRONIC TYPE-B HEPATITIS
    HOOFNAGLE, JH
    DUSHEIKO, GM
    SEEFF, LB
    JONES, EA
    WAGGONER, JG
    BALES, ZB
    [J]. ANNALS OF INTERNAL MEDICINE, 1981, 94 (06) : 744 - 748
  • [9] AGE-SPECIFIC PREVALENCE OF HEPATITIS-BE ANTIGEN (HBEAG) AND ANTIBODY TO HBEAG (ANTI-HBE) AMONG ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN (HBSAG) CARRIERS IN OKINAWA AND KYUSHU, JAPAN
    KASHIWAGI, S
    HAYASHI, J
    NOMURA, H
    KAJIYAMA, W
    IKEMATSU, H
    SHINGU, T
    HAYASHIDA, K
    KAJI, M
    [J]. MICROBIOLOGY AND IMMUNOLOGY, 1986, 30 (07) : 675 - 682
  • [10] TRANSMISSION OF HEPATITIS-B VIRUS AMONG SIBLINGS
    KASHIWAGI, S
    HAYASHI, J
    IKEMATSU, H
    NOMURA, H
    KAJIYAMA, W
    SHINGU, T
    HAYASHIDA, K
    KAJI, M
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1984, 120 (04) : 617 - 625